Kimberly-Clark Corporation

KMB's portfolio of diapers, facial tissue, feminine care, and adult care consists of everyday consumables purchased on repeating cycles, giving the business above-average demand visibility without backlog or contractual guarantees. Organic sales grew within a 2-4% corridor across FY2022-FY2025, including through the 2022 inflationary period, indicating consistent volume demand from the category.

Personal Care is the largest segment at roughly 53% of continuing-operation revenues, with Consumer Tissue at roughly 31% and K-C Professional at 16%. No single product line is dominant enough to constitute concentrated risk, but the segments serve broadly correlated consumer staples end markets with limited uncorrelated revenue streams.

Following the planned joint venture with Suzano S.A. encompassing substantially all International Family Care and Professional operations, continuing revenues are concentrated in North America at approximately 75-80% of the reporting base, with a smaller International Personal Care segment providing limited offset. A predominantly single-region footprint amplifies exposure to North American retail dynamics and US consumer trends.

KMB's manufacturing model is asset-intensive with multi-plant networks for tissue and personal care requiring sustained capital expenditure. Gross margin compressed from roughly 37% in FY2020 to below 31% in FY2022 under input cost pressure before recovering to roughly 38% in FY2024, illustrating that incremental cost leverage is offset by fiber, energy, and distribution cost cycles.

Diapers, facial tissue, feminine care, and adult incontinence products are everyday necessities with near-zero discretionary substitution, producing a highly durable demand base. While revenue is not contractual, repeat-purchase cadences are among the most consistent in consumer goods and the categories face structurally non-discretionary demand.